主动脉弓动脉瘤修复手术风险被低估了吗?基于30天与1年死亡率的新视角
这项国际双中心研究纳入2006至2020年间456例因动脉瘤行全主动脉弓置换的患者,比较术后30天与1年死亡率。1年生存概率为81%(95%CI 78-85%),低于30天的92%(95%CI 90-95%),死亡风险在出院后前4个月最高。卒中、肾衰竭、呼吸衰竭和因出血再手术与30天存活患者的1年死亡率相关,作者认为评估手术风险时可将短期以外的死亡纳入考量。
要点
- 全主动脉弓置换后1年生存概率81%低于30天92%,死亡风险在出院后前4个月最高。
- 30天存活患者中,卒中、肾衰竭、呼吸衰竭和因出血再手术与1年死亡率相关。
- 作者认为评估全主动脉弓置换手术风险时可将短期以外的死亡纳入考量。
核心结论
- 主动脉弓置换后死亡率在术后1年内持续增加,增加集中在出院后前4个月,并与术后并发症相关,提示手术创伤的影响。
- 作者认为,在评估接受全主动脉弓置换患者的手术风险时,可将短期以外的死亡纳入考量。
研究设计与样本
- 国际双中心研究,纳入2006年至2020年间因动脉瘤行全主动脉弓置换的456例患者。
- 主要终点为1年死亡率,次要分析确定与1年死亡率相关的变量。
主要发现
- 患者中位年龄65.4岁(四分位距55.1-71.1),女性118例(25.9%)。
- 91例(20.0%)患者同期行主动脉根部置换或主动脉瓣手术。
- 1年生存概率为81%(95%CI 78-85%),低于30天生存概率92%(95%CI 90-95%)。
- 风险危害回归显示出院后前4个月死亡风险最高。
- 30天存活患者中,卒中(HR 2.54,95%CI 1.16-5.58)、肾衰竭(HR 3.59,95%CI 1.78-7.25)、呼吸衰竭(HR 3.65,95%CI 1.79-7.42)和因出血再手术(HR 2.97,95%CI 1.36-6.46)与1年死亡率相关。
临床怎么用
- 作者认为,在评估接受全主动脉弓置换患者的手术风险时,可将短期以外的死亡纳入考量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The decision to undergo aortic aneurysm repair balances the risk of operation with the risk of aortic complications. The surgical risk is typically represented by perioperative mortality, while the aneurysmal risk relates to the 1-year risk of aortic events. We investigate the difference in 30-day and 1-year mortality after total arch replacement for aortic aneurysm. METHODS: This was an international two-centre study of 456 patients who underwent total aortic arch replacement for aneurysm between 2006 and 2020. Our primary end-point of interest was 1-year mortality. Our secondary analysis determined which variables were associated with 1-year mortality. RESULTS: The median age of patients was 65.4 years (interquartile range 55.1-71.1) and 118 (25.9%) were female. Concomitantly, 91 (20.0%) patients had either an aortic root replacement or aortic valve procedure. There was a drop in 1-year (81%, 95% confidence interval (CI) 78-85%) survival probability compared to 30-day (92%, 95% CI 90-95%) survival probability. Risk hazards regression showed the greatest risk of mortality in the first 4 months after discharge. Stroke [hazard ratio (HR) 2.54, 95% CI (1.16-5.58)], renal failure [HR 3.59 (1.78-7.25)], respiratory failure [HR 3.65 (1.79-7.42)] and reoperation for bleeding [HR 2.97 (1.36-6.46)] were associated with 1-year mortality in patients who survived 30 days. CONCLUSIONS: There is an increase in mortality up to 1 year after aortic arch replacement. This increase is prominent in the first 4 months and is associated with postoperative complications, implying the influence of surgical insult. Mortality beyond the short term may be considered in assessing surgical risk in patients who are undergoing total arch replacement.
引用
- Rajesh K, Levine D, Murana G, et al. Is surgical risk of aortic arch aneurysm repair underestimated? A novel perspective based on 30-day versus 1-year mortality. Eur J Cardiothorac Surg. 2024. PMID: 38318956. doi:10.1093/ejcts/ezae041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。